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Fig 1. Fluorescence intensity before and after revascularization.
Fig 2. Average increase in maximum ﬂuorescence.
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measured perfusion dynamics with clinical outcomes.
Methods: ICGA was used to measure perfusion dynamics before and
after revascularization in patients with critical limb ischemia. ICGA of the
foot provides an objective, quantiﬁable measurement of inﬂow and outﬂow
of blood in the foot (Fig 1). The total ﬂuorescence curves were ﬁtted to a
logistical equation and maximum intensity, maximum ingress rate, time to
maximum intensity, and time to half-maximum intensity were calculated.
Patients were followed up for clinical correlation for a minimum of 6
months and divided into two groups, those whose wounds healed vs
freedom from a major adverse limb event.
Results: The mean increase in ﬂow after revascularization was 25%
(range, 6%-55%), time to maximum intensity decreased by an average of
13 seconds (range, 1.1-25 seconds), time to half-maximum intensity
decreased by an average of 4 seconds (range, 0-8.5 seconds), and maximum
ingress rate increased by an average of 11% (range, e23% to 38%). When
comparing the patients who had successful vs failed revascularization, there
was a trend towards faster rates of ingress and shorter time to maximum in-
tensity. However, for patients who had successful outcomes deﬁned as at
least 6 months amputation-free and not requiring reintervention, themost signiﬁcant difference was the increase in maximum ﬂuorescence signal
(51% vs 7%, Fig 2).
Conclusions: ICGA can be used as a functional study to look at skin
perfusion dynamics to better predict end points of revascularization proce-
dures and predict potential failures of therapy, despite successful angiographic
results. There is a need to better identify objective, visual data to evaluate tis-
sue perfusion in real-time. Initial results of ICGA are promising because the
measured dynamics appear to correlate clinically. ICGA provides a rapid, safe,
and easy method for evaluating revascularization procedures.
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Objectives: The role of endovascular aneurysm repair (EVAR) in
young patients is controversial. The purpose of this study was to determine
the long-term outcomes and reintervention rates in patients aged #60
years who underwent elective open or EVAR of an abdominal aortic
aneurysm.
Methods: All patients aged #60 years who underwent elective
abdominal aortic aneurysm repair between 2000 and 2013 were identiﬁed
during a retrospective review of our center’s prospectively maintained data-
base. Preoperative anatomic measurements were performed and compared
with endografts’ instructions for use (IFU) criteria.
Results: A total of 169 patients aged #60 years (mean age, 56.7 6
2.8 years) underwent elective repair (119 open, 50 EVAR). Patients
treated with open repair and EVAR had similar comorbidities, except
EVAR patients were more likely to have hypertension (P ¼ .03) and
poor left ventricular function (P ¼ .04). The open repair group had signif-
icantly more angulated suprarenal (P ¼ .004) and infrarenal neck angles (P
¼ .005), shorter neck lengths (P < .001) and larger maximal aneurysm
diameter (P ¼ .015) compared with the EVAR group. Only ﬁve patients
(10%) in the EVAR group did not meet all IFU criteria. The overall in-
hospital mortality rate was 1.8% (0% EVAR, 2.5% open, P ¼ .56). Overall
mean life expectancy was 11.5 years (9.8 years EVAR, 11.9 years; P ¼
.09). One-year (98% EVAR, 96% open), 5-year (86% EVAR, 88% open),
and 10-year (54% EVAR, 75% open) survival did not differ between
EVAR and open (P ¼ .16). Long-term survival (78% EVAR, 85.1%
open; P ¼ .09) and reintervention rates (12% EVAR, 15.8% open; P ¼
.805) did not differ. No late aneurysm rupture or aneurysm-related deaths
were observed. The most common causes of long-term mortality were ma-
lignancy and cardiovascular events. Reinterventions in the open group
were exclusively access related (incisional hernia repairs), whereas all rein-
terventions in the EVAR group were aortic related, including one conver-
sion to open repair.
Conclusions: With adherence to IFU criteria, EVAR results in similar
durability and long-term survival compared with open repair in young pa-
tients aged #60 years. Long-term mortality in these young patients is
Fig 1. The traditional metric for predicting arteriovenous ﬁstula (AVF)
success failed to correlate with postoperative size at the point of assay.
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Objectives: Large proportions of hemodialysis arteriovenous ﬁstulas
(AVFs) fail to mature for unclear reasons. These constructions develop in
a large mass of surrounding adipose tissue that increasingly is recognized
as an active vascular response to injury participant via paracrine/endocrine
mechanisms. We thus hypothesized that baseline phenotypic characteristics
of the adipose juxtaposed to the developing AVF would be associated with
subsequent inward or outward vein wall remodeling.
Methods: Clinical data and subcutaneous adipose tissue were
collected from 22 consented patients undergoing AVF creation. Tissue
was assayed (protein levels) for interleukin (IL)-6, IL-8, leptin, tumor ne-
crosis factor (TNF)-a, monocyte chemotactic protein (MCP)-1, resistin,
and adiponectin. Duplex ultrasound vein dimensions were acquired preop-
eratively and at a single point 1 cm cephalad to the arteriovenous anasto-
mosis (most common location of AVF stenosis) at 4 to 6 weeks
postoperatively.
Results: The Table describes the cohort. The vein at the assayed loca-
tion outwardly remodeled 22% on average (range, 3.66 0.2-5.66 0.5 mm;
P ¼ .005). The traditional metric for predicting AVF success (preoperative
vein diameter) failed to correlate with postoperative size at the point of assay
(R ¼ 0.31, P ¼ .155; Fig 1). Conversely, the correlation coefﬁcients be-
tween venous diameter change (preoperative vs postoperative) and IL-8,
TNF-a, MCP-1, resistin, and adiponectin were e0.49, e0.79, e0.66,
e0.64, and e0.69 respectively (P < .05; Fig 2). Postoperative AVF ﬂow
volume correlated with MCP-1 (e0.53, P < .05) and adiponectin
(e0.47, P < .05).Table. Demographic and clinical data
Characteristic No. (%) (N ¼ 22)
BMI, kg/m2 29.4 6 7.3
Age, years 66.8 6 13.0
Male gender 17 (77.3)
Ethnicity
White, non-Hispanic 11 (50.0)
Hispanic 3 (13.6)
Black 6 (27.3)
Asian 2 (9.1)
Procedure
Radial-cephalic 8 (36.4)
Brachial-cephalic 12 (54.6)
Brachial-basilic 2 (9.1)
Comorbidities
Diabetes mellitus 17 (77.3)
Hypertension 20 (90.9)
Any h/o tobacco use 15 (68.2)
Medications
b-Blocker 18 (81.8)
Calcium channel blocker 15 (68.2)
ACEI 11 (50.0)
ARB 11 (50.0)
a-Agonist 10 (45.5)
Nitrate 15 (68.2)
Diuretic 15 (68.2)
Acetylsalicylic acid 17 (77.3)
Warfarin 11 (50.0)
Clopidogrel 11 (50.0)
Statin 19 (86.4)
ACEI, Angiotensin-converting enzyme inhibitor; ARB, angiotensin recep-
tor blocker; BMI, body mass index; h/o, history of.
Fig 2. Correlation coefﬁcient between venous diameter change and inter-
leukin (IL)-8, tumor necrosis factor (TNF)-a, monocyte chemotactant
protein (MCP)-1, resistin, and adiponectin.
yNew England Society for Vascular SurgeryConclusions: These striking results point to a previously undescribed
relationship between local adipose phenotype and the eventual venous wall
response to hemodynamic perturbation in humans. The predictive value of
these adipokines exceeded that of preoperative vein size. Beyond providing
mechanistic insights into vascular wall adaptations due to ﬂow perturba-
tions, this discovery suggests that strategies focused on altering adipose tis-
sue biology may enhance AVF maturation.
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